Company Directory - Research & Development
The clinical development of drugs and devices is crucial for human welfare. Our mission is to improve success rates in this endeavor.
We do this by improving the design and implementation of clinical trials through the innovative application of stat
DNA Script was created to revolutionize DNA write with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM, the world’s first benchtop DNA printer powered by enzymatic technology.
We discover and develop medicines to defeat neurodegeneration. We are applying deep scientific and drug development expertise to discover effective molecular therapeutics and have engineered a proprietary technology to deliver biologic therapeutics to the brain.
At DiCE Molecules, we design and develop innovative therapies in immunology for patients with chronic diseases. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, we are developing oral alternatives to medicines currently limited to injectable forms.
Sustainability focused consultancy with specialisms in medtech, health innovation, public health, lab testing, and environmental performance. Applies AI, digitisation and digitalisation to boost clients' performance.
Established in 1941, Eisai is a pharmaceutical company operating globally in terms of R&D, manufacturing, distribution and marketing, with a strong focus on prescription medicines.
Enara Bio™ (formerly known as Ervaxx) is a science-led company targeting the T-cell/cancer cell interface (the “immune synapse”) to develop new targeted cancer immunotherapies designed to treat a broad patient population.
We are fully equipped and well-positioned to realize the potential of Encoded’s novel approach to gene therapy for people living with pediatric central nervous system (CNS) diseases and their families.
We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high medical need.
Epithelix Sàrl provides alternative in vitro solutions to animal experimentation for evaluating the effects of drugs in development and assess the toxicity of chemical compounds on the human respiratory tract. Epithelix is a biotech company founded in March 2006 and located in Geneva, Switzerland.
We research, develop and commercialize high quality, affordable, ready-to-formulate ingredients that are based on nature and are available at all times, in any quantity. We believe in applying technology platforms, such as fermentation, to help resolve sourcing bottlenecks in nature.
